
As specialty drug complexity grows, agentic technology puts the right access, adherence, and affordability resources at the provider’s fingertips at prescribing.
Future Market Insights recently published research findings that the global enzyme replacement therapy market is predicted to increase at 6.5% CAGR over the forecast period 2018–2028. It also finds the global market for enzyme replacement therapy is expected to exceed $ 13,776.2 million (US dollars) by the end of 2028, attesting the highest growth rate by Japan, which is expected to expand at 12.5% CAGR over 2018–2028. The developing healthcare infrastructure and awareness programs in regions of Asia Pacific and China is expected to play a part in revenue growth for the global enzyme replacement therapy market.
Some key research findings include:






